Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 1991
ISBN 10: 0632024844 ISBN 13: 9780632024841
Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
EUR 5,61
Anzahl: 2 verfügbar
In den WarenkorbZustand: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 1991
ISBN 10: 0632024844 ISBN 13: 9780632024841
Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
EUR 5,61
Anzahl: 1 verfügbar
In den WarenkorbZustand: Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 1991
ISBN 10: 0632024844 ISBN 13: 9780632024841
Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
EUR 5,61
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
EUR 25,02
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
Sprache: Englisch
Verlag: McFarland and Company, Inc., 2011
ISBN 10: 0786464275 ISBN 13: 9780786464272
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 27,54
Anzahl: 15 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
EUR 27,53
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 34,65
Anzahl: 15 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Sprache: Englisch
Verlag: McFarland & Company, Jefferson, NC; London, 2010
ISBN 10: 078646366X ISBN 13: 9780786463664
Anbieter: Voyageur Book Shop, Milwaukee, WI, USA
Erstausgabe
Soft cover. Zustand: Fine. First Trade Edition. X12.
Zustand: fine. 2011, 269pp, paperback in goede staat.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 41,14
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 52,08
Anzahl: 15 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
EUR 50,93
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 269 pages. 9.80x7.00x0.80 inches. In Stock.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 52,75
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Houtman Boeken, Utrecht, Niederlande
Zustand: fine. 2010, 551pp, Nette paperback.
EUR 33,06
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Presents 369 British films produced between 1937 and 1964 that embody many of the same filmic qualities as those black films made in the United States during the classic film noir era. This reference work makes a case for the inclusion of the British fi.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 71,89
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 551 pages. 10.00x7.00x1.25 inches. In Stock.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Oxidative Stress and Vascular Disease | John F. Keaney Jr. | Taschenbuch | xvii | Englisch | 2012 | Springer | EAN 9781461371038 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 226,05
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 226,05
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - One of the major biomedical triumphs of the post-World War II era was the defmitive demonstration that hypercholesterolemia is a key causative factor in atherosclerosis; that hypercholesterolemia can be effectively treated; and that treatment significantly reduces not only coronary disease mortality but also all cause mortality. Treatment to lower plasma levels of cholesterol - primarily low density lipoprotein (LDL) cholesterol - is now accepted as best medical practice and both physicians and patients are being educated to take aggressive measures to lower LDL. We can confidently look forward to important decreases in the toll of coronary artery disease over the coming decades. However, there is still uncertainty as to the exact mechanisms by which elevated plasma cholesterol and LDL levels initiate and favor the progression of lesions. There is general consensus that one of the earliest responses to hypercholesterolemia is the adhesion of monocytes to aortic endothelial cells followed by their penetration into the subendothelial space, where they differentiate into macrophages. These cells, and also medial smooth muscle cells that have migrated into the subendothelial space, then become loaded with mUltiple, large droplets of cholesterol esters . . . the hallmark of the earliest visible atherosclerotic lesion, the so-called fatty streak. This lesion is the precursor of the more advanced lesions, both in animal models and in humans. Thus the centrality of hypercholesterolemia cannot be overstated. Still, the atherogenic process is complex and evolves over a long period of time.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - One of the major biomedical triumphs of the post-World War II era was the defmitive demonstration that hypercholesterolemia is a key causative factor in atherosclerosis; that hypercholesterolemia can be effectively treated; and that treatment significantly reduces not only coronary disease mortality but also all cause mortality. Treatment to lower plasma levels of cholesterol - primarily low density lipoprotein (LDL) cholesterol - is now accepted as best medical practice and both physicians and patients are being educated to take aggressive measures to lower LDL. We can confidently look forward to important decreases in the toll of coronary artery disease over the coming decades. However, there is still uncertainty as to the exact mechanisms by which elevated plasma cholesterol and LDL levels initiate and favor the progression of lesions. There is general consensus that one of the earliest responses to hypercholesterolemia is the adhesion of monocytes to aortic endothelial cells followed by their penetration into the subendothelial space, where they differentiate into macrophages. These cells, and also medial smooth muscle cells that have migrated into the subendothelial space, then become loaded with mUltiple, large droplets of cholesterol esters . . . the hallmark of the earliest visible atherosclerotic lesion, the so-called fatty streak. This lesion is the precursor of the more advanced lesions, both in animal models and in humans. Thus the centrality of hypercholesterolemia cannot be overstated. Still, the atherogenic process is complex and evolves over a long period of time.